庆祝儿童1型糖尿病胰岛素治疗百年
本文回顾了1921年多伦多团队成功分离降糖胰腺内分泌物,并于1922年治疗一名14岁消瘦男孩,使其恢复健康并存活13年。此后胰岛素氨基酸序列和晶体结构阐明、放射免疫分析法开发、重组人胰岛素合成及胰岛素笔、泵和连续血糖监测的应用,使儿童1型糖尿病从致死性疾病转为可管理的慢性病。
要点
- 1921年多伦多团队分离出降糖胰腺内分泌物,1922年治疗14岁男孩恢复健康。
- 胰岛素相关研究获多项诺贝尔奖,包括氨基酸序列、晶体结构和放射免疫分析法。
- 重组人胰岛素及胰岛素笔、泵、连续血糖监测改善代谢控制和生活质量。
核心结论
- 胰岛素治疗使儿童1型糖尿病从 uniformly fatal 转为可管理的慢性病。
研究设计与样本
- 本文为历史回顾性叙述,描述胰岛素发现、诺贝尔奖相关研究及给药技术进展。
主要发现
- 1921年多伦多团队成功分离葡萄糖降低性胰腺内分泌分泌。
- 1922年治疗一名14岁消瘦男孩,恢复健康并使其再存活13年。
- 人胰岛素是首个通过重组方法合成的激素,允许修饰以改善吸收速率和改变作用持续时间。
- 胰岛素笔、可编程泵和连续血糖监测联合应用,大幅改善代谢控制和生活质量。
临床怎么用
- 临床可依据本史实向患儿家庭说明胰岛素治疗使1型糖尿病成为可管理的慢性病。
局限性
- 本文为历史叙述,未报告原始研究样本量、效应量或统计学比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Insulin is the key anabolic hormone of metabolism, with clear effects on glycaemia. Near-complete insulin deficiency occurs in type 1 diabetes (T1D), the predominant form affecting children, and uniformly fatal until the discovery of insulin. By the early 20th century, it was known that T1D was caused by the lack of a factor from pancreatic islets, but isolation of this substance proved elusive. In 1921, an unusual team in Toronto comprising a surgeon, a medical student, a physiologist and a biochemist successfully isolated a glucose-lowering pancreatic endocrine secretion. They treated an emaciated 14-year-old boy in 1922, restoring his health and allowing him to live for another 13 years. Thus began an era of remarkable progress and partnership between academia and the pharmaceutical industry to produce drugs that benefit sick people. The Toronto team received the 1923 Nobel Prize, and more Nobel Prizes for work with insulin followed: for elucidation of its amino acid sequence and crystalline structure, and for its role in the development of radioimmunoassays to measure circulating hormone concentrations. Human insulin was the first hormone synthesised by recombinant methods, permitting modifications to enable improved absorption rates and alterations in duration of action. Coupled with delivery via insulin pens, programmable pumps and continuous glucose monitors, metabolic control and quality of life vastly improved and T1D in children was converted from uniformly fatal to a manageable chronic condition. We describe this remarkable ongoing story as insulin remains a paradigm for human ingenuity to heal nature's maladies.
引用
- Rogol AD, Laffel LM, Bode B, et al. Celebration of a century of insulin therapy in children with type 1 diabetes. Arch Dis Child. 2022. PMID: 35725290. doi:10.1136/archdischild-2022-323975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。